Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy: what progress in the last 5 years?

× No keyword cloud information.

23 in total

1. Concomitant adjuvant chemo-radiation therapy with anthracycline-based regimens in breast cancer: a single centre experience.

Authors: L Livi; I Meattini; V Scotti; C Saieva; G Simontacchi; L Marrazzo; C Franzese; S Cassani; F Paiar; V Di Cataldo; J Nori; L Jose Sanchez; S Bianchi; L Cataliotti; G Biti
Journal: Radiol Med Date: 2011-03-07 Impact factor: 3.469

2. A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity.

Authors: Sanjib Bhattacharyya; Maria Gonzalez; J David Robertson; Resham Bhattacharya; Priyabrata Mukherjee
Journal: Chem Commun (Camb) Date: 2011-06-30 Impact factor: 6.222

Review 3. Inorganic nanoparticles in cancer therapy.

Authors: Sanjib Bhattacharyya; Rachel A Kudgus; Resham Bhattacharya; Priyabrata Mukherjee
Journal: Pharm Res Date: 2010-11-23 Impact factor: 4.200

Review 4. [Future of chemotherapy].

Authors: M-O Grimm; F H Hartmann; R Ackermann
Journal: Urologe A Date: 2006-05 Impact factor: 0.639

5. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program.

Authors: Oxana G Palesh; Joseph A Roscoe; Karen M Mustian; Thomas Roth; Josée Savard; Sonia Ancoli-Israel; Charles Heckler; Jason Q Purnell; Michelle C Janelsins; Gary R Morrow
Journal: J Clin Oncol Date: 2009-11-23 Impact factor: 44.544

Review 6. Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer.

Authors: Erin M Bertino; Bhuvaneswari Ramaswamy
Journal: Breast Cancer (Dove Med Press) Date: 2010-05-24

7. Ixabepilone (ixempra), a therapeutic option for locally advanced or metastatic breast cancer.

Authors: Nancy Egerton
Journal: P T Date: 2008-09

8. Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.

Authors: Olivia Pagani; Karen N Price; Richard D Gelber; Monica Castiglione-Gertsch; Stig B Holmberg; Jurij Lindtner; Beat Thürlimann; John Collins; Martin F Fey; Alan S Coates; Aron Goldhirsch
Journal: Breast Cancer Res Treat Date: 2009-01-10 Impact factor: 4.872

9. Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.

Authors: R Sánchez-Escribano Morcuende; J E Alés-Martínez; P M Aramburo González
Journal: Clin Transl Oncol Date: 2007-07 Impact factor: 3.405

10. State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments.

Authors: Arnd Honig; Lorenz Rieger; Marc Sutterlin; Diethelm Wallwiener; Johannes Dietl; Erich-Franz Solomayer
Journal: Ger Med Sci Date: 2005-09-13